JP Patent

JP7260258B2 — 蓋つき容器、多重容器、及び蓋つき容器の組み立て方法

Assigned to Shiseido Co Ltd · Expires 2023-04-18 · 3y expired

What this patent protects

Patent listed against ropivacaine-hydrochloride.

Drugs covered by this patent

ropivacaine-hydrochloride (ROPIVACAINE HYDROCHLORIDE)

Patent Metadata

Patent number: JP7260258B2
Jurisdiction: JP
Classification: —
Expires: 2023-04-18
Drug substance claim: No
Drug product claim: No
Assignee: Shiseido Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.